The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Introduction. This study estimates health-related quality of life (HRQoL) or utility decrements associated with type 1 diabetes mellitus (T1DM) using data from a UK research program on the Dose Adjustment For Normal Eating (DAFNE) education program. Methods. A wide range of data was collected from 2341 individuals who undertook a DAFNE course in 2009–2012, at baseline and for 2 subsequent years. We use fixed- and random-effects linear models to generate utility estimates for T1DM using different instruments: EQ-5D, SF-6D, and EQ-VAS. We show models with and without controls for HbA1c and depression, which may be endogenous (if, for example, there is reverse causality in operation). Results. We find strong evidence of an unobserved individual effect, suggesting the superiority of the fixed-effects model. Depression shows the greatest decrement across all the models in the preferred fixed-effects model. The fixed-effects EQ-5D model also finds a significant decrement from retinopathy, body mass index, and HbA1c (%). Estimating a decrement using the fixed-effects model is not possible for some conditions where there are few new cases. In the random-effects model, diabetic foot disease shows substantial utility decrements, yet these are not significant in the fixed-effects models. Conclusion. Utility decrements have been calculated for a wide variety of health states in T1DM that can be used in economic analyses. However, despite the large data set, the low incidence of several complications leads to uncertainty in calculating the utility weights. Depression and diabetic foot disease result in a substantial loss in HRQoL for patients with T1DM. HbA1c (%) appears to have an independent negative impact on HRQoL, although concerns remain regarding the potential endogeneity of this variable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797 · cited 1×
“We anticipated that the SF-6D would be more sensitive to mild changes in health, whereas the EQ-5D might show a greater decrement for more severe health states.(53) Indeed, the EQ-5D can give a much lower possible value to a health state than is possible with the SF-6D: the minimum value possible for the EQ5D is –0.”
BackgroundHopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265 · cited 2×
“This can be found in Hopkins and others.(26) If individuals did not report a complication, it is assumed that they do not have one (this arose for about a third of cases that had EQ-5D data).”
BackgroundMethodSelf-citationSpeight, J., Amiel, S. A., Bradley, C., Heller, S., Oliver, L., Roberts, S., Rogers, H., Taylor, C., & Thompson, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.017 · Cited by 160
Strachan, M. W., Deary, I. J., Ewing, F. M., & Frier, B. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.305 · Cited by 113 · cited 1×
“Events such as DKA and hypoglycemic episodes are likely to have a direct impact on HRQoL while they are being experienced and during the recovery period.(35) The utility measures administered at a particular point in time may not identify this trajectory of severe health shock followed by recovery.”
BackgroundElliott, J., Jacques, R. M., Kruger, J., Campbell, M. J., Amiel, S. A., Mansell, P., Speight, J., Brennan, A., & Heller, S. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12441 · Cited by 112
Self-citationFenwick, E. K., Xie, J., Ratcliffe, J., Pesudovs, K., Finger, R. P., Wong, T. Y., & Lamoureux, E. L. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8992 · Cited by 101
Cited by
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Choi, J. G., Winn, A. N., Skandari, M. R., Franco, M. I., Staab, E. M., Alexander, J., Wan, W., Zhu, M., Huang, E. S., Philipson, L., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-2941 · Cited by 87
Heller, S., White, D., Lee, E., Lawton, J., Pollard, D., Waugh, N., Amiel, S., Barnard, K., Beckwith, A., Brennan, A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21200 · Cited by 73
“2 of the model were considered for updating by the new information presented in Peasgood et al.(112) and Beaudet et al.”
MethodSelf-citationChatwin, H., Broadley, M., Speight, J., Cantrell, A., Sutton, A., Heller, S., de Galan, B., Hendrieckx, C., & Pouwer, F. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108752 · Cited by 53
Willis, M., Nilsson, A., Kellerborg, K., Ball, P., Roe, R., Traina, S., Beale, R., & Newell, I. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00968-x · Cited by 36
Metadata
- Authors
- Peasgood, T., Brennan, A., Mansell, P., Elliott, J., Basarir, H., & Kruger, J.
- Venue
- Medical Decision Making
- Publisher
- SAGE Publications
- Published
- 2016-09-27
- Volume
- 36
- Issue
- 8
- Pages
- 1020-1033
- ISSN
- 0272-989X (ISSN-L)
- 1552-681X
- OpenAlex
- W2338517537
- Cited by
- 66
- References
- 6
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. https://app.cochat.ai/papers/10.1177/0272989x16658660
- The paper
- Peasgood, T., Brennan, A., Mansell, P., Elliott, J., Basarir, H., & Kruger, J. (2016). The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. Medical Decision Making. https://doi.org/10.1177/0272989x16658660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.